Use of epo receptor activation or stimulation for the improvement of the edss score in patients with multiple sclerosis
US2009036359A1
Use of erythropoietin and substances increasing and/or prolonging the activation and/or stimulation of erythropoietin receptors for treating and/or preventing schizophrenia and related psychoses
DE102006004008A1
Treating or preventing multiple sclerosis comprises administering erythropoietin for periods separated by intervals in which no erythropoietin is administered
DE10043457A1
Processes for treating schizophrenia and related psychoses, and using erythropoietin or erythropoietin derivatives to treat schizophrenia and related psychoses
DE19857609A1
Use of erythropoietin for the treatment of human cerebral ischemia
